Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Search
About Us
Sign in
Chemical Industry News, Data & Insights
About Us
Sign in
Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Products
WEEKLY
FOCUS
ALPHA
Project Updates and Milestones news
(page 8)
16 July 2026
Infinium supplies eNaphtha for On's CleanCloud EVA midsole
CO₂‑derived eNaphtha used as a drop‑in feedstock to produce EVA midsoles at commercial scale; shipments began in 2024, ISCC PLUS chain‑of‑custody, and more than one million pairs produced.
16 July 2026
MOL: USD 100 million interim insurance payment for Danube Refinery fire
Insurers admitted liability and will pay USD 100 million as an interim settlement; repairs aim to restore full refinery capacity by end-Q3 2026 after an October 2025 unit fire.
16 July 2026
EIB approves €17.4bn financing package including €800m for Cernavodă and Ukraine border upgrades
€17.4bn package backs energy projects, an €800m Cernavodă loan, securitisation expansion and upgraded Ukraine–EU crossings.
16 July 2026
WISA Group Plc: Finnish regulator approves demerger and listing prospectus; leadership team appointed
Regulator approved the Finnish-language prospectus for the plywood carve-out; EGM, demerger completion and Nasdaq Helsinki listing set for Aug–Nov 2026.
16 July 2026
Gasunie positions the Netherlands as Europe’s CO₂ hub
Five connected CCS projects (Porthos, Aramis, CO₂next, DRC, DSC) will capture, transport and store CO₂ under the North Sea and link industry across the Netherlands, Belgium and Germany.
16 July 2026
Lilly to acquire AtaiBeckley to add rapid-acting neuroplastogen pipeline
Adds BPL-003 (mebufotenin benzoate intranasal) and VLS-01 (DMT buccal); upfront $6.75/share plus up to $2.50/share CVR tied to development, regulatory and DEA-rescheduling milestones.
The right choices in the European chemical industry
Save time with
chemXplore Alpha
Learn more
16 July 2026
Merck’s LIPFENDRA — first FDA‑approved once‑daily oral PCSK9 inhibitor
Oral macrocyclic peptide enlicitide (20 mg) lowers LDL-C ~56–59% at week 24 in Phase 3 trials; approved as adjunct to diet and exercise for adults with hypercholesterolemia, including HeFH.
16 July 2026
Uniper supplies Q1 Energie AG with bio‑LNG
Initial delivery expands bio‑LNG availability for heavy road transport; biomethane is liquefied at Gate Rotterdam, shipped in ISO tanks to Germany and distributed to filling stations.
16 July 2026
BASF inaugurates Düsseldorf emollients plant
Mid double-digit million-euro investment expands capacity for specialty emollients used in skin care and sun protection, serving European and global cosmetics markets.
16 July 2026
Evonik completes backward integration of MetAMINO® network with Mobile methyl mercaptan unit
On-site methyl mercaptan production is now in Antwerp, Singapore and Mobile, completing integration and trimming DL‑methionine’s carbon footprint by ~7% while cutting hazardous intermediate transport.
15 July 2026
Repsol, Toyota, BMW and Bosch pilot cars on 100% renewable gasoline
Six-month Spanish trial uses existing cars, 100% renewable gasoline and digital tracking to demonstrate drop-in fuel scalability without new vehicles or infrastructure.
15 July 2026
Novo Nordisk wins EU authorisation for Wegovy pill and single‑dose 7.2 mg pen
OASIS data showed ~17% mean weight loss and ~1 in 3 reached ≥20%; safety comparable to injectable semaglutide; wider roll‑out planned in H2 2026.
15 July 2026
PureCycle, Mitsui and RM TOHCELLO to bring recycled PP to BOPP film in Japan
Aiming to introduce recycled polypropylene into BOPP flexible packaging; pilot runs successful and a commercial agreement is targeted for 2027 ahead of shipments subject to import clearance.
15 July 2026
Merck to present daily, weekly and monthly HIV data at AIDS 2026
Late‑breakers include Week 48 results for once‑weekly islatravir+lenacapavir and Week 24 data for islatravir+ulonivirine; once‑monthly PrEP trials are enrolling.
15 July 2026
Merck KEYTRUDA improves PFS vs platinum chemotherapy in dMMR endometrial cancer (Phase 3)
Phase 3 trial finds pembrolizumab monotherapy improves PFS versus platinum doublet chemotherapy in dMMR advanced or recurrent endometrial cancer.
15 July 2026
Axens to build France’s first industrial-scale Jetanol™ SAF unit
50,000 t/y SAF plant using advanced bioethanol and Jetanol™ technology; production targeted for 2030 to boost French/European SAF supply and meet ReFuelEU targets.
15 July 2026
Roche: FDA grants Priority Review for Gazyva/Gazyvaro (obinutuzumab) in primary membranous nephropathy
Priority Review follows MAJESTY phase III showing 36.9% complete remission at two years vs 5.7% with tacrolimus; FDA decision expected by Nov 2026.
15 July 2026
Anglo Asian Mining hires Worley for Xarxar and Garadag copper feasibility studies
Feasibility studies for two Azerbaijan copper deposits will assess heap‑leach and SX‑EW processing; Xarxar due mid‑2027, Garadag H1 2028; ~90,000 m drilling planned.
14 July 2026
Sonatrach launches 140,000 m3/day desalination plant construction in Ben M’Hidi, Skikda
Two-year build to supply Skikda industrial area and ADE; project managed by ADC with works executed by ENAC, both Sonatrach subsidiaries.
14 July 2026
Genentech’s Gazyva (obinutuzumab) granted FDA priority review for primary membranous nephropathy
FDA granted priority review for obinutuzumab in pMN after Phase III MAJESTY showed markedly higher complete remission vs tacrolimus; FDA decision expected Nov 2026.
14 July 2026
Olin and Huntsman: SEC Declares S‑4 Effective for Planned Merger
SEC declared the Form S‑4 effective; special shareholder meetings set for Aug 25; closing expected H1 2027; transaction targets >$400M in synergies and broader vertical integration.
14 July 2026
PCC SE: Revenue +5–10% to nearly €1bn and EBITDA +20%+ expected in FY2026
Forecasts revenue near €1bn, EBITDA rising over 20% to a three‑digit million, and a return to EBIT profit; Q2 figures due Aug 20, 2026.
14 July 2026
Mitsui Chemicals to establish MC Dental Holdings America as oral-care global HQ
New US holding will become the global headquarters for the group's oral care business after the Ultradent acquisition; establishment moved up to July 2026.
14 July 2026
BP Q2 2026 trading statement
Lower reported upstream volumes from seasonal Gulf maintenance and Middle East disruption; stronger oil and refining realizations; net debt cut to $22–23bn; post-tax impairments about $1bn.
14 July 2026
Topsoe and Sasol license G2L SAF technology to Allied Biofuels for Uzbekistan plant
License and engineering deal to supply G2L eSAF and bio‑SAF technology for a Khorezm plant producing about 300,000 t SAF/eSAF annually; FID 2027, commercial ops targeted 2030.
14 July 2026
Acelen Renewables and Bunge sign five-year certified soybean oil supply for SAF and HVO
Five-year supply of 300,000 t/yr certified soybean oil (total >1 Mt) for SAF and renewable diesel at a Bahia biorefinery due to start operations in 2029.
13 July 2026
Rivus Batteries raises €2 million to scale critical‑mineral‑free flow battery chemistry
€2m seed plus €2m in grants to scale an organic, critical‑mineral‑free flow battery electrolyte compatible with commercial flow battery hardware.
13 July 2026
Galp 2Q26 trading update and Moeve downstream talks
Moeve tie-up aimed for H2 2026; provisional 2Q26 shows 127 kboepd production, $16.8/boe refining margin and 2.3 GW renewables capacity.
13 July 2026
EIB lends €450m to OMV for Bruck green hydrogen plant
140 MW electrolyser at Bruck will produce 23,000 t/yr renewable hydrogen, feed Schwechat refinery via 22 km pipeline, cutting direct CO₂ by up to 150,000 t/yr; operations due end‑2027.
13 July 2026
Rompetrol Energy tests island-mode operation at Petromidia cogeneration plant
Plant can start and run without National Energy System power; tested with Transelectrica and Nuclearelectrica; capacity ~80 MWh and 180 t/h steam; can feed surplus to grid.
← Previous
Next →
